Tuesday, October 19, 2021

All sessions are conducted through video webcasts and will take place in the Eastern time zone.  Provided below is the current Emerging Growth Conference schedule for featured presentations. Each company’s presentations will be delivered by their executive management team.

Agenda

Can B Corp. (OTCQB: CANB) is a health & wellness company providing the highest quality hemp derived cannabinoid products. 

Keynote speakers: Marco Alfonsi, CEO & Stanley Teeple, CFO 

Pressure Biosciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries.

Keynote speaker: Richard T. Schumacher, President / CEO

Stemtech Corporation (OTC Pink: GNTW) is a leading nutraceutical company with a direct sales distribution model specializing in creating products and formulas that are patent-protected in the U.S. and in select international markets. 

Keynote speaker: John Meyer, COO

Aurus Technologies has four tokens (AWG), (AWS), (AWP) which are backed by 1 gram of Gold, Silver, and Platinum.  AWX is a revenue-sharing token that entitles its holders to a portion of the revenues generated from AWG, AWS and AWP 

Keynote speaker: Jonathan Boyd, Director of Institutional Markets

PetVivo Holdings Inc. (NASDAQ: PETV) is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals.

Keynote speaker: John Lai, CEO

UC Asset LP (OTCQX: UCASU) is a limited partnership formed for the purpose of investing in real estate with innovative strategies, concentrating in metropolitan areas of Atlanta, GA.

Keynote speaker: Greg Bankston, CEO & Christal Jordan, Executive Director – Marketing and Sales

Remark Holdings, Inc. (NASDAQ: MARK) delivers an integrated suite of AI solutions that enable businesses and organizations to solve problems, reduce risk and deliver positive outcomes. 

Keynote speakers: Kai-Shing Tao, Chairman / CEO & E. Brian Harvey, Senior VP

CytoDyn, Inc. (OTCQB: CYDY) is a late-stage biotechnology company developing innovative treatments for multiple therapeutic indications using leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor.

Keynote speakers: Dr. Nader Pourhassan, President / CEO & Dr. Scott Kelly, Chief Med. Officer

The Emerging Growth Conference focus and coverage includes a wide range of growth sectors and timely market themes, including, augmented reality, artificial intelligence, scientific, medical instruments and therapeutics, biotechnologies, cannabis, food & beverage, energy and more.

Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally.

The presentations to be delivered by the presenting companies (including any handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with the offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

Thank you for your interest in our conference, and we look forward to your participation in future conferences.